A recently published research article reported that the extreme halophile archaebacterium Natronobacterium gregoryi Argonaute enzyme (NgAgo) could cleave the cellular DNA under physiological temperature conditions in cell line and be implemented as an alternative to CRISPR/Cas9 genome editing technology. We assessed this claim in mouse zygotes for four loci (Sptb, Tet-1, Tet-2 and Tet-3) and in the human HEK293T cell line for the EMX1 locus. Over 100 zygotes were microinjected with nls-NgAgo-GK plasmid provided from Addgene and various concentrations of 5'phosphorylated guide DNA (gDNA) from 2.5 ng/µl to 50 ng/µl and cultured to blastocyst stage of development. The presence of indels was verified using T7 endonuclease 1 assay (T7E1) and Sanger sequencing. We reported no evidence of successful editing of the mouse genome. We then assessed the lack of editing efficiency in HEK293T cell line for the EMX1 endogenous locus by monitoring the NgAgo protein expression level and the editing efficiency by T7E1 assay and Sanger sequencing. We reported that the NgAgo protein was expressed from 8 hours to a maximum expression at 48 hours posttransfection, confirming the efficient delivery of the plasmid and the gDNA but no evidence of successful editing of EMX1 target in all transfected samples. Together our findings indicate that NgAgo is unsuitable as a genome editing tool.
The type II CRISPR/Cas9 genome editing system offers the ability to efficiently and precisely edit DNA using a combination of the Cas9 endonuclease enzyme and a single guide RNA gRNA [1] . However the requirement of a specific protospacer adjacent motif (PAM) sequence limits the ability of the Cas9 enzyme to edit any nucleotide of a genome. Recently a report described a novel genome editing technology based on the archaebacterium Natrnobacterium gregoryi Argonaute (NgAgo) enzyme. Gao et al. undeniably important therapeutic potential [3] . We sought to assess the efficiency of NgAgo in two different systems: mouse zygotes and the HEK293T human cell line to determine the suitability of NgAgo as an alternative to the CRISPR/Cas9 genome editing tool. Here we report our attempts to edit the mouse and human genomes using NgAgo.
We synthetized the gDNA and co-microinjected in mouse zygotes with the nls-NgAgo-GK plasmid vector provided by Gao et al. We also co-transfected the gDNA with a modified Flag-nls-NgAgo-GK plasmid into HEK293T cells and assessed the DNA editing using T7 endonuclease assay and Sanger sequencing. We monitored the expression of the protein for the first 48 hours post-transfection in HEK293T cells. We found no evidence for a double strand break and editing of the DNA under various conditions and optimizations. We concluded that NgAgo is unsuitable as a genome editing tool.
To assess NgAgo efficiency to create a double strand break under the guidance of a single gDNA as described in Gao et al. [2] we used mouse zygotes as a system model.
We firstly co-injected mouse zygotes with the nls-NgAgo-GK plasmid and the gDNA targeting four different genes (Sptb, Tet1, Tet2 and Tet3) . The gDNA selected were previously shown to edit efficiently (over 90% efficiency) as an sgRNA with CRISPR/Cas9 mediated genome editing [4] . Initially, we targeted exon 26 of Sptb in mouse zygotes ( Figure 1A ). We titrated the gDNA at various concentrations (2.5, 25 or 50 ng/µl) and co-injected with 5 ng/µl of nls-NgAgo-GK plasmid, provided by Gao et al. and available at Addgene, into the pronucleus of the fertilized zygotes. The zygotes were cultured for 4 days to the blastocyst stage of development. From the 20 bastocysts that were genotyped (gDNA at 2.5 ng/µl: 6 blastocysts, gDNA at 25 ng/µl: 8 blastocysts, gDNA at 50 ng/µl: 6 blastocysts), we found the amplification of a band corresponding to the expected amplicon length for Sptb ( Figure 1B ). We performed a T7 endonuclease assay (T7E1) and Sanger sequencing to identify indels. We could not identify any indels from the T7E1 assay ( Figure 1C and 1D) and the Sanger sequencing ( Figure 1E ). We then hypothesized the lack of editing could be gene specific, hence we decided to assess three other genes; exon 5 of Tet-1 (Suppl Figure 1A) , exon 3 of Tet-2 (Suppl Figure 1B) and exon 5 of Tet-3 (Suppl Figure 1C ) as described previously [4] . The zygotes were coinjected with 5ng/µl of nls-NgAgo-GK plasmid and 2.5 ng/µl of gDNA. We constantly found one band using gel electrophoresis corresponding to the expected amplicon size for Tet-1 (10 blastocysts), Tet-2 (14 blastocysts) and Tet-3 (13 blastocysts). We performed a T7E1 assay and genotyped the blastocysts by Sanger sequencing. We found again, no evidence for the presence of indels (data not shown). We further assessed the NgAgo editing efficiency for Sptb and Tet-2 on pups born from the microinjection sessions. We performed a T7E1 assay and Sanger sequencing to assess the editing efficiency and we did not find any indels, suggesting no successful editing for Sptb (0/9 with 50 ng/µl of gDNA and 5 ng plasmid, and 0/12 with 25 ng/µl of gDNA and 5 ng plasmid) and for Tet-2 (0/4 with 25 ng/µl of gDNA and 5 ng plasmid (data not shown)). Together, this suggests that NgAgo failed to generate indels for the four analyzed mouse loci (Sptb, Tet-1, Tet-2 and Tet-3) in over 84 mouse blastocysts and 25 mouse pups, suggesting NgAgo does not create a double strand break nor that it is capable of editing the mouse genome.
We therefore speculated this lack of editing activity could be due to the degradation of the protein within the cell. To address this hypothesis, we tagged the protein with a flag tag upstream of the nls signal (Flag-nls-NgAgo-GK, Figure 1E ) and monitored the expression of the protein and whether NgAgo edited the DNA in the HEK293T cell line at various time points from 8 to 48 hours post lipofection with or without the gDNA for exon 3 of the EMX1 gene ( Figure 1F ). We used an anti-flag antibody to probe for NgAgo expression, and utilised GAPDH as a loading control. We first conducted a PCR and a T7E1 assay on the NgAgo-EMX1-lipofectamine treated cells to determine whether the DNA was edited. We found no evidence for editing in any NgAgo-lipofection samples at 8 and 12 hours post-transfection ( Figure 1F ). Similarly, there was no editing for the additional time points of 24 and 48 hours post transfection ( Supplementary Figure 2 A and B). We therefore speculated that the NgAgo protein could be rapidly degraded after transfection and required a specific timing to edit the DNA. To verify this hypothesis, we followed the kinetics of the NgAgo protein production and degradation from 8 to 48 hours post transfection. We noticed the NgAgo protein expression started at 8 hours and persisted over 48 hours post transfection ( Figure 1G ), with maximum expression being observed at 48 hours post transfection compared to 8 hours (p = 0.02) ( Figure 1G and Supplementary Figure 3) suggesting an efficient delivery of NgAgo and the gDNA.
Interestingly, we noticed the presence of small-Flag-tagged fragments by 8 hours post transfection, suggesting the protein started degrading, with the fragment intensity reaching its peak at 48 hours post-transfection associated with the peak protein expression mentioned above with and without the co-transfection of the gDNA ( Figure   1G ). We saw no difference in protein expression and degradation with or without the gDNA (p = 0.0631 and p = 0.25 repsectively) ( Figure 1G and Supplementary Figure 3 ).
Therefore, since degradation of the protein is the same between NgAgo treated samples with and without gDNA, the difference in protein expression is unlikely to be due to this rapid degradation.
Gao et al. reported that NgAgo creates a double strand break in the DNA using a single DNA guide [2], with a reported efficiency equivalent to Cas9. Importantly, and in agreement with recently published reports [5-7], we found strictly no evidence of a double strand break of the DNA with NgAgo, and no editing of the mouse and human DNA despite an efficient delivery of NgAgo and the gDNA. We did not observe an editing event in over 100 mouse embryos injected with NgAgo, giving an editing efficiency of less than 1%, contradicting the results reported in Gao et al. Interestingly, we found in the mouse embryos, mouse pups and in the HEK293T human cell line no evidence of a single indel using a T7E1 assay, and confirmed by Sanger sequencing.
In summary, in contradiction with Gao et al's study, and in agreement with recently published reports, we found that NgAgo does not edit endogenous genomic DNA under physiological temperature conditions. Acknowledgments: This work was supported from the National Collaborative Research Infrastructure (NCRIS) through the Australian Phenomics Network in Australia. We would like to thank all the comments, anonymous or not on the initial blogpost, on Twitter and or on a Google discussion group dedicated to genome editing technology that have led to stimulating, interesting and fruitful discussions on this technique. 
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#5" C57BL/6 and recipient ICR females were purchased from Charles River laboratory and maintained in a specific pathogen-free environment at the Australian Phenomics Facility, Primer Name Sequence
the Australian National University. Mice were maintained on a 12h light/12h dark cycle and had ad libitum access to food and water ad libitum. Female C57BL/6 (3-4 weeks old, >10g)
were superovulated by intraperitoneal injection of 5IU of pregnant mare serum gonadotropin (PMSG), followed by 5IU of human chorionic gonadotropin hormone (hCG) 46-48 hours later. Following injection with hCG, superovulated females were mated with stud C57BL/6 males (10-20 weeks old). The embryos were collected from oviducts approximately 45 hours after the last injection and held in M16 medium (Sigma M7292) overlaid with mineral oil at 37ºC and 5% CO 2 until injection.
Microinjection was performed in M2 medium (Sigma, M7167) under mineral oil using an inverted microscope (Leica DMi8) and micromanipulators. Pronuclear injection of fertilized zygotes was performed with the following mixes: circular plasmid DNA at 5 ng/µl and 5'-P oligonucleotide at 2.5, 25 and 50 ng/µl. Microinjected zygotes were cultured overnight in M16. Resulting two-cell embryos were surgically transferred into the ampulla of pseudoplugged ICR female recipients (8-12 weeks old).
Genotyping:
A subset of the microinjected zygotes was cultured for 4 days to the blastocyst stage in M16 medium overlaid with mineral oil at 37ºC and 5% CO 2 . The other zygotes were cultured for 24 hours and surgically transferred into the surrogate mouse ampulla. The mice were maintained and the resulting pups were maintained and genotyped 15 days after birth. DNA was extracted from the blastocysts at day 5 or live mouse pups over 15 days old using a crude DNA extraction protocol. In short, the blastocysts were lysed in Tris-EDTA-Tween lysis buffer (50mMTris HCl, pH8.0, 0.125mM EDTA, 2% Tween 20) with 1µl of proteinase K (20 mg/ml in 10mM Tris chlorate, 0.1 mM ethylenediaminetretaacetic acid (EDTA) pH 8.0) and incubated at 56ºC for an hour with before being denatured at 95ºC for 10 minutes.
We amplified regions encompassing the gDNA with 2x MyTaq HS mix (Bioline, cat no.
BIO-25045) under the following PCR conditions: 95ºC for 3 minutes followed by 35 cycles (95ºC for 15", 58ºC for 15" and 72ºC for 20") and 72ºC for 3 minute. The PCR products were checked on a 1.5% electrophoresis gel. The PCR products were purified with#ExoSAP-IT® (affymetrix, Cat no. 78202), or cut from the gel and purified using the Wizard® SV Gel and PCR Clean-Up System (Promega, Cat no. A9282) kit according to the manufacturer's instructions. The Sanger sequencing was conducted at the Biomedical Resource Facility at the John Curtin School for Medical Research, The Australian National University.
T7 endonuclease assay.
After PCR amplification, the PCR fragments were hybridized and digested with a T7 endonuclease (NEB, Cat no. M0302S) for 15-30 minutes at 37ºC. After digestion, the enzymatic reaction was stopped using 1 µl of 0.25 M EDTA and the digested product run on a 1.5% agarose gel alongside the undigested PCR product as a control.
Construction of a Flag-nls-NgAgo-GK plasmid:
The nls-NgAgo-GK plasmid was obtained from Addgene (78253). nls-NgAgo-GK plasmid was digested overnight with AleI (NEB, cat no. R0634S). Following the digestion a forward E. coli. The plasmid is being deposited at Addgene and will be available to the community.
Cell culture and transfection:
HEK293T cells were obtained from ATCC (CRL-11268 Millipore Cat no MAB374) were diluted in 1% skim milk in PBS and incubated for 1 hour at RT with shaking. After incubation, membranes were washed with 1xPBS+0.1%Tween for three times 5 mins and once for 10 mins. After washing, membranes were incubated with secondary antibody (1:5000 goat anti-mouse Ig-HRP, Sigma Cat no. A44161ML) diluted in 1% skim milk in PBS, for 1 hour at RT with shaking, and then washed again as above.
Membrane was visualised under chemiluminescence with HRP substrate (Millipore, Cat no. WBLUF0500) at various exposure times.
Analysis and Statistics:
Using ImageJ 1.05i software, Western blot membranes were analyzed for the mean band intensity for anti-FLAG (corresponding to the expression of NgAgo), as well as for the loading control anti-GAPDH. The relative abundance of anti-FLAG was determined as a ratio of the loading control to produce a FLAG:GAPDH ratio. These ratios were then normalized to the negative control, containing no NgAgo. These values were then analysed as listed below.
A Two-Way ANOVA using Tukey's multiple comparisons test was performed to quantify changes in protein expression over time for each treatment. Paired T-tests were performed to compare protein expression over time between NgAgo samples with and without gDNA. A two-tailed Wilcoxon test was performed to examine changes in degradation between samples with or without gDNA. All analyses were conducted using the GraphPad software, Prism 7, with significance at P≤0.05.
